The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease

Islam Mohammad Shehata, Waniyah Masood, Nouran Nemr, Alexandra Anderson, Kamal Bhusal, Amber N. Edinoff, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye

Open source

DOI
10.3390/neurolint14020025
Published
2022-03-22
Container
Neurology International
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/neurolint14020025,
  title = {The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease},
  author = {Islam Mohammad Shehata and Waniyah Masood and Nouran Nemr and Alexandra Anderson and Kamal Bhusal and Amber N. Edinoff and Elyse M. Cornett and Adam M. Kaye and Alan D. Kaye},
  year = {2022},
  journal = {Neurology International},
  doi = {10.3390/neurolint14020025},
  url = {https://doi.org/10.3390/neurolint14020025}
}

RIS

TY  - JOUR
TI  - The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
AU  - Islam Mohammad Shehata
AU  - Waniyah Masood
AU  - Nouran Nemr
AU  - Alexandra Anderson
AU  - Kamal Bhusal
AU  - Amber N. Edinoff
AU  - Elyse M. Cornett
AU  - Adam M. Kaye
AU  - Alan D. Kaye
PY  - 2022
JO  - Neurology International
DO  - 10.3390/neurolint14020025
UR  - https://doi.org/10.3390/neurolint14020025
ER  - 

APA

Shehata, I. M., Masood, W., Nemr, N., Anderson, A., Bhusal, K., Edinoff, A. N., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022). The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease. Neurology International. https://doi.org/10.3390/neurolint14020025

Source records